Article
PODCAST: Why This Recession is Different
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Feb 20, 2026 / Kevin Duffy
The GDP Illusion: Surging Statistics Hide Pain for Average Americans
True prosperity cannot be measured by aggregate spending totals prone to manipulation and malinvestment, but by private-sector health, wage gains across income levels, and genuine productive investment.
Read more
Feb 21, 2026 / Tyler Durden
Deporting Censorship: US Targets UK Government Ally Over Free Speech
Deporting Censorship: US Targets UK Government Ally Over Free Speech
Authored by Paul D. Thacker via RealClearInvestigations,
As ICE sweeps in Minneapolis have drawn wide attention, a little-noticed immigration case playing out in a New York federal court has significant implications for America’s relationship with Britain and the ongoing debate over global censorship.
In late December, the State Department announced its intention to revoke the visas of five foreign individuals who have allegedly censored Americans. The most consequential member of this group is Imran Ahmed, a British Labour Party political operative now...
Read more
Feb 24, 2026 / Tyler Durden
Novo Nordisk Extends Slide After Announcing Price-Cuts For Blockbuster Obesity Drugs
Novo Nordisk Extends Slide After Announcing Price-Cuts For Blockbuster Obesity Drugs
Novo Nordisk shares in Copenhagen can't catch a bid. The liquidation is accelerating again after a Bloomberg headline on Tuesday morning: the Danish drugmaker will slash U.S. list prices for Wegovy and Ozempic next year. The move suggests that the new CEO is pursuing market share amid intensifying competition in the GLP-1 space.
Jamey Millar, Novo's head of U.S. operations, was quoted by Bloomberg as saying the company set a monthly price of $675 for its family of semaglutide drugs,...
Read more


